NCT05135468View on ClinicalTrials.gov

A Phase 3 Clinical Study Patients With Androgenetic Alopecia (AGA)

PHASE3CompletedINTERVENTIONAL
Enrollment

270

Participants

Timeline

Start Date

December 6, 2021

Primary Completion Date

March 7, 2023

Study Completion Date

May 15, 2023

Conditions
AGA
Interventions
DRUG

CU-40102 Spray

topical application, 1\~4 sprays each time, once daily

Trial Locations (1)

100044

Peking University People Hosptial, Beijing

Sponsors
All Listed Sponsors
lead

Cutia Therapeutics（Wuxi）Co.,Ltd

INDUSTRY